How should palpation findings be evaluated in an adult?

Evaluation of Palpable Findings in Adults

For adults presenting with a palpable breast mass, imaging evaluation with diagnostic mammography (age ≥40 years) or ultrasound (age <30 years) is mandatory before any tissue sampling, as palpation alone cannot reliably distinguish benign from malignant lesions or even confirm the presence of a true mass. 1

Key Principle: Palpation Has Limited Diagnostic Accuracy

Physical examination findings are inherently unreliable for characterizing breast masses:

• Only 58% of palpable cysts are correctly identified by palpation alone 1
• Four experienced surgeons agreed on biopsy necessity in only 73% of subsequently proven malignant masses 1
• A suspicious physical examination should prompt biopsy regardless of negative imaging findings, but imaging must still be performed first 1

Age-Based Imaging Algorithm

Women ≥40 Years Old

1. Start with diagnostic mammography or digital breast tomosynthesis (DBT) 1

   • Place radiopaque marker over palpable site
   • Include spot compression and magnification views as needed
   • Sensitivity of mammography alone: 86-91% 1

2. Add targeted ultrasound to the palpable area 1

   • Detects 93-100% of cancers occult on mammography 1
   • Identifies 40% of benign masses not seen on mammography 1
   • Combined negative predictive value >97% 1

Women <30 Years Old

Ultrasound is the initial and often only imaging modality needed 1

• Breast cancer risk is substantially lower (1 in 53 chance from birth to age 49 vs. 1 in 15 at age 70) 1
• Mammography typically not indicated unless ultrasound findings are suspicious

Women 30-39 Years Old

Clinical judgment determines whether to start with ultrasound or add mammography based on risk factors and clinical suspicion 1

What Imaging Can Definitively Identify

Clearly Benign Findings (No Further Workup Needed)

If imaging shows these correlates to the palpable finding, clinical follow-up only is appropriate 1:

• Lymph node
• Hamartoma
• Lipoma
• Calcified fibroadenoma
• Oil cyst
• Simple cyst on ultrasound

Probably Benign Findings (BI-RADS 3)

For solid masses with benign ultrasound features (oval/round shape, well-defined margins, homogeneous, parallel orientation):

• Short-interval imaging follow-up is acceptable instead of immediate biopsy 1
• Cancer incidence in this category: 0.3-2.0% 1
• Exception: Biopsy immediately if patient is high-risk, awaiting transplant, has synchronous cancer, or planning pregnancy 1

Tissue Sampling When Indicated

Image-guided core needle biopsy is superior to fine-needle aspiration 1:

• Better sensitivity and specificity
• Provides correct histological grading
• Allows receptor status evaluation
• Ultrasound guidance preferred when correlate identified

Critical timing: Perform imaging before any biopsy, as post-biopsy changes obscure interpretation 1

What NOT to Do

No Role for These Modalities in Initial Evaluation:

• MRI (with or without contrast) 1
• PET mammography (FDG-PEM) 1
• Nuclear medicine (Tc-99m sestamibi) 1
• Immediate biopsy without imaging 1

Common Pitfalls to Avoid

1. Never let negative imaging override highly suspicious palpation findings - proceed to biopsy 1
2. Never let benign-appearing palpation override suspicious imaging - proceed to biopsy
3. Don't perform biopsy before imaging - it compromises subsequent image interpretation 1
4. Don't assume you can distinguish cysts from solid masses by palpation - you cannot 1

Special Circumstances

Pregnant or lactating women: Ultrasound is first-line, but mammography is not contraindicated if malignancy suspected (effective for detecting calcifications and architectural distortion) 1

Post-lumpectomy palpable lump: MRI may help distinguish scar from recurrence, though evidence is limited 1

The negative predictive value of combined mammography and ultrasound reaches 97.4-100% 1, making this multimodality approach highly reliable when both are negative and clinical suspicion is low.